Abstract
Summary A method is described for the staining of typhus rickettsiae with fluorescent antibody. Convalescent human or guinea pig sera are used in an indirect or in a complement staining procedure. Fluorescent antibody procedures are readily adapted to antibody absorption (or inhibition) techniques, and advantage is taken of this fact to differentiate murine from epidemic typhus sera. A group of sera from human beings and guinea pigs convalescent from murine or epidemic typhus fever gave results with the expected specificity, but three of 14 presumed murine typhus sera from humans had indeterminate specificity or specificity directed toward epidemic typhus rickettsiae. Two instances were observed of laboratory personnel who received epidemic typhus vaccine and subsequently were accidentally infected with murine typhus rickettsiae. In both cases the antibody formed during infection had specificity directed toward epidemic rickettsiae. Guinea pigs were given epidemic or murine typhus vaccines and then infected with murine or epidemic typhus rickettsiae. As a result of infection the homologously challenged animals formed antibody characteristic of the infecting rickettsia, but many of those receiving heterologous challenge formed antibody characteristic of the vaccine.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
